EODData

MEMBERSHIP REGISTER LOG IN

FRA, 8E8: ELICERA THERAPEUTICS AB

19 Nov 2025
LAST:

0.4635

CHANGE:
 0.00		OPEN:
0.4635		HIGH:
0.4635		ASK:
0.0000		VOLUME:
250
CHG(%):
0.65		PREV:
0.4605		LOW:
0.4635		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Nov 250.46350.46350.46350.4635250
18 Nov 250.46050.46050.46050.4605250
17 Nov 250.47100.47100.47100.4710250
13 Nov 250.46350.46350.46350.4635250
12 Nov 250.46750.46750.46750.4675250
11 Nov 250.46800.46800.46800.4680250
10 Nov 250.48700.48700.48700.4870250
07 Nov 250.48300.48300.48300.4830250
06 Nov 250.51100.51100.51100.5110250
05 Nov 250.52400.52400.52400.5240250

PROFILE

Name:ELICERA THERAPEUTICS AB
About:Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:World Trade Center Göteborg, Gothenburg, Sweden, 412 51
Website:https://www.elicera.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.06 
PEG Ratio:0.02 
Price to Sales:4.62 
Price to Book:0.88 
Profit Margin:-2.64 
Operating Margin:-1.07 
Return on Assets:-0.28 
Return on Equity:-0.57 
Revenue:546.9K 
Shares:48.54M 
Market Cap:22.5M 

TECHNICAL INDICATORS

MA5:0.470.4%
MA10:0.483.5%
MA20:0.519.2%
MA50:0.5313.4%
MA100:0.5212.1%
MA200:0.438.7%
STO9:5.94 
STO14:3.68 
RSI14:34.49 
WPR14:-96.32 
MTM14:-0.06
ROC14:-0.11 
ATR:0.01 
Week High:0.471.6%
Week Low:0.460.7%
Month High:0.5620.6%
Month Low:0.468.7%
Year High:0.6947.8%
Year Low:0.11317.6%
Volatility:27.84